The FDA’s Center for Drug Evaluation & Research has formed an AI Council to oversee the implementation and regulation of Artificial Intelligence in drug development. Given the rapid expansion of AI and machine learning initiatives into all stages of drug design and clinical trials, this is an important step forward.

Source: https://lnkd.in/efSK9x8S